Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Channick

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
American Heart Journal|April 2, 2025
A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE studyRachel P Rosovsky, Stavros V Konstantinides, John M Moriarty, et al.
Pulmonary Circulation|January 26, 2023
The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patientsElizabeth Louw, Nicola Baines, Gerald Maarman, et al.
Journal of the American College of Cardiology|June 15, 2004
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertensionHossein A Ghofrani, Joanna Pepke-Zaba, Joan A Barbera, et al.
The European Respiratory Journal|August 29, 2024
Pulmonary hypertension associated with lung diseasesOksana A Shlobin, Yochai Adir, Joan A Barbera, et al.
Cardiology and Therapy|March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS DatasetRichard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
Chest|October 25, 2024
Association Between Thrombus Histopathology and Hemodynamic Outcomes Among Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary EndarterectomyLouisa A Mounsey, Daniel Alape Moya, Cameron Wright, et al.
Hospital Practice (1995)|February 26, 2014
The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolismTim Provias, David M Dudzinski, Michael R Jaff, et al.
Journal of the American College of Cardiology|December 21, 2013
Chronic thromboembolic pulmonary hypertensionNick H Kim, Marion Delcroix, David P Jenkins, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Chronic thromboembolic pulmonary hypertension]Nick H Kim, Marion Delcroix, David P Jenkins, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
American Heart Journal|April 2, 2025
A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE studyRachel P Rosovsky, Stavros V Konstantinides, John M Moriarty, et al.
Pulmonary Circulation|January 26, 2023
The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patientsElizabeth Louw, Nicola Baines, Gerald Maarman, et al.
Journal of the American College of Cardiology|June 15, 2004
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertensionHossein A Ghofrani, Joanna Pepke-Zaba, Joan A Barbera, et al.
The European Respiratory Journal|August 29, 2024
Pulmonary hypertension associated with lung diseasesOksana A Shlobin, Yochai Adir, Joan A Barbera, et al.
Cardiology and Therapy|March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS DatasetRichard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
Chest|October 25, 2024
Association Between Thrombus Histopathology and Hemodynamic Outcomes Among Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary EndarterectomyLouisa A Mounsey, Daniel Alape Moya, Cameron Wright, et al.
Hospital Practice (1995)|February 26, 2014
The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolismTim Provias, David M Dudzinski, Michael R Jaff, et al.
Journal of the American College of Cardiology|December 21, 2013
Chronic thromboembolic pulmonary hypertensionNick H Kim, Marion Delcroix, David P Jenkins, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Chronic thromboembolic pulmonary hypertension]Nick H Kim, Marion Delcroix, David P Jenkins, et al.
Pageof 8